EFFECTIVENESS OF USTEKINUMAB DOSE ESCALATION IN CROHN'S DISEASE

被引:0
|
作者
Ollech, Jacob
Normatov, Inessa
Peleg, Noam
Patel, Shivani
Rai, Victoria
Wang, Jingzhou D.
Yi, Yangtian
Singer, Jorie
Dalal, Sushila
Sakuraba, Atsushi
Cohen, Russell D.
Rubin, David T.
Pekow, Joel R.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1882
引用
下载
收藏
页码:S961 / S961
页数:1
相关论文
共 50 条
  • [21] Effectiveness of dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous ustekinumab maintenance therapy: A multicentre international cohort study
    Kopylov, U.
    Hanzel, J.
    Liefferinckx, C.
    De Marco, D.
    Imperatore, N.
    Plevris, N.
    Baston-Rey, I.
    Harris, R.
    Truyens, M.
    Domislovic, V.
    Vavricka, S.
    Biemans, V.
    Myers, S.
    Shaji, S.
    Ben-Horin, S.
    Gonzalez Lama, Y.
    Gilletta, C.
    Shitrit, A. Bar-Gil
    Zelinkova, Z.
    Weishof, R.
    Storan, D.
    Zittan, E.
    Franchimont, D.
    Cremer, A.
    Afif, W.
    Castiglione, F.
    Lees, C.
    Barrero de Acosta, M.
    Lobaton, T.
    Doherty, G.
    Krznaric, Z.
    Pierik, M.
    Hoentjen, F.
    Drobne, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S111 - S111
  • [22] EFFECTIVENESS OF USTEKINUMAB FOR MANAGEMENT OF EXTRAINTESTINAL MANIFESTATIONS OF CROHN'S DISEASE
    Aboubakr, Aiya
    Battat, Robert
    Galati, Jonathan S.
    Ahmed, Waseem
    Scherl, Ellen J.
    Longman, Randy S.
    Lukin, Dana J.
    GASTROENTEROLOGY, 2021, 160 (06) : S701 - S701
  • [23] RISANKIZUMAB DOSE ESCALATION IN PATIENTS WITH CROHN'S DISEASE
    Nichols, Patrick
    Kozlicki, Miranda
    Fann, Jessica
    Zuckerman, Autumn
    Dalal, Robin
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S88 - S89
  • [24] Safety and effectiveness of ustekinumab in elderly Crohn's disease patients
    Fiske, Joseph
    Liu, Eleanor
    Limdi, Jimmy K.
    Conley, Thomas E.
    Townsend, Tristan
    Davies, Mike
    Brockwell, Robert
    Baig, Daniyal
    Abdelbadiee, Sherif
    Uney, Anastasia
    Liaros, Angela
    Gaba, Waqas
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (11) : 1132 - 1139
  • [25] Ustekinumab in Crohn's disease: effectiveness and safety in clinical practice
    Saldana Duenas, Cristina
    Rullan Iriarte, Maria
    Elosua Gonzalez, Alfonso
    Rodriguez Gutierrez, Cristina
    Rubio Iturria, Saioa
    Nantes Castillejo, Oscar
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (09): : 497 - 505
  • [26] Long term outcomes following de-escalation of dose-intensified ustekinumab in patients with Crohn's disease
    Demase, K.
    Smith, R. L.
    Luber, R.
    Taylor, K. M.
    Ward, M. G.
    Sparrow, M. P.
    Little, R. D.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1317 - I1317
  • [27] Ustekinumab for Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (01): : 9 - 9
  • [28] REAL LIFE EFFECTIVENESS OF USTEKINUMAB FOR MODERATE TO SEVERE CROHN'S DISEASE
    Miranda, A.
    Cuomo, A.
    Camera, S.
    Ciacci, C.
    De Filippo, F. R.
    D'Onofrio, V.
    Melina, R.
    Manguso, F.
    Bennato, R.
    Cuomo, R.
    Mucherino, C.
    Facchiano, A.
    Rigler, G.
    Sgambato, D.
    Ciamarra, P.
    Romano, M.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S38 - S38
  • [29] Assessing the safety and effectiveness of 4 weekly Ustekinumab in Crohn's disease
    Sewell, Charlotte
    Cooney, Rachel
    GUT, 2023, 72 (SUPPL_2) : A113 - A113
  • [30] Early real-world effectiveness of ustekinumab for Crohn's disease
    Harris, Richard James
    McDonnell, Martin
    Young, David
    Bettey, Marion
    Downey, Louise
    Pigott, Lucinda
    Felwick, Richard
    Gwiggner, Markus
    Cummings, J. R. Fraser
    FRONTLINE GASTROENTEROLOGY, 2020, 11 (02) : 111 - 116